United States
Search    
Include All CSL Behring Country Sites

Junior National Championship (JNC) Program

2012 Junior National Championship Sponsored by CSL Behring

Gettin' in the GameSM Junior National Championship

Developed by CSL Behring, the Gettin' in the Game GIG Junior National Championship (JNC) was the first national golf and baseball competition designed specifically for the bleeding disorders community. The program features gives children with bleeding disorders an opportunity to compete in golf and baseball and provides education and information-sharing opportunities for participants and their parents/caregivers.

  • The JNC features accomplished GIG athletes, who themselves have been diagnosed with bleeding disorders, such as hemophilia and von Willebrand disease. These athletes hold clinics to help educate children and their families about the fundamentals of golf and baseball and provide support to encourage participants to remain active as part of managing their condition.

  • Since the first JNC in 2002, CSL Behring has brought the competition to more than 30 towns across the US and has helped nearly 1,000 competitors and their families connect with other members of the bleeding disorders community.

  • The JNC encourages kids with bleeding disorders, such as hemophilia and von Willebrand disease, to stay physically active, to learn more about their disease state, and to regularly connect with their treatment provider to effectively manage their condition.

With GIG, CSL Behring nurtures a community. In the spirit of that collaboration, the program fosters genuine connections as children with bleeding disorders and their families meet and share experiences.

Remember, before engaging in any physical activity always, consult with a healthcare professional to make sure that the activity is right for you.


The commitment behind the community

CSL Behring is committed to connecting people with bleeding disorders to other members of the community who share their experiences. This commitment is demonstrated by our development and maintenance of innovative, high-quality programs, such as the JNC, but also by the company’s range of therapies used in the treatment of a variety of bleeding disorders, such as hemophilia and von Willebrand disease.

MTL07-12-0002 10/2012
© 2014 CSL Behring